VIVUS Announces Date of Fourth Quarter and Fiscal Year 2012 Financial Results
and Conference Call
MOUNTAIN VIEW, Calif., Feb. 20, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc.
(Nasdaq:VVUS) today announced that it will report financial results for the
fourth quarter and year ended December 31, 2012 after the Nasdaq Market closes
on Monday, February 25, 2013. The company will conduct a conference call and
an audio webcast at 4:30pm EST the same day.
Date: February 25, 2013
Time: 4:30 PM EST
Listen via Internet: http://ir.vivus.com/
U.S. Toll-free: 877-359-2916
Outside U.S.: (+) 224-357-2386
A webcast replay will be available on the VIVUS website for 30 days.
VIVUS is a biopharmaceutical company commercializing innovative therapies to
address unmet needs in obesity and sexual health for U.S., Europe and other
world markets. Qsymia is also in phase 2 clinical development for the
treatment of type 2 diabetes and obstructive sleep apnea. For more information
about the company, please visit www.vivus.com.
Certain statements in this press release are forward-looking within the
meaning of the Private Securities Litigation Reform Act of 1995. These
statements may be identified by the use of forward-looking words such as
"anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely,"
"may," "plan," "potential," "predict," "opportunity" and "should," among
others. There are a number of factors that could cause actual events to differ
materially from those indicated by such forward-looking statements. VIVUS does
not undertake an obligation to update or revise any forward-looking
statements. Investors should read the risk factors set forth in VIVUS' Form
10-K for the year ending December 31, 2011, and periodic reports filed with
the Securities and Exchange Commission.
CONTACT: VIVUS, Inc.
Timothy E. Morris
Chief Financial Officer
Financial Media Relations:
Joele Frank, Wilkinson Brimmer Katcher
The Trout Group
Press spacebar to pause and continue. Press esc to stop.